2574-42-7 Usage
General Description
Bicyclo[2.2.2]octan-1-yl methanol, also known as the Endo-methanohydrophenanthrene, is a chemical compound with a bicyclic structure. It is a colorless liquid with a slightly sweet odor, and is commonly used in the fragrance and flavor industry. This chemical is mainly used as a fragrance ingredient in personal care products, perfumes, and household items. It can also be used as a flavoring agent in food and beverages. Bicyclo[2.2.2]octan-1-yl methanol is known for its ability to provide a fresh and clean scent, and is often used in combination with other fragrance ingredients to enhance the overall scent profile of a product. Additionally, it has been found to have potential applications in the pharmaceutical and medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 2574-42-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,7 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2574-42:
(6*2)+(5*5)+(4*7)+(3*4)+(2*4)+(1*2)=87
87 % 10 = 7
So 2574-42-7 is a valid CAS Registry Number.
2574-42-7Relevant articles and documents
MITOCHONDRIA-TARGETING PEPTIDES
-
, (2020/07/14)
Disclosed are analogs of SBT-20. The compounds are useful for the treatment and prevention of ischemia-reperfusion injury (e.g., cardiac ischemia-reperfusion injury) or myocardial infarction.
MITOCHONDRIA-TARGETING PEPTIDES
-
Page/Page column 62; 63, (2019/07/19)
Disclosed are non-natural peptides useful for the treatment and prevention of ischemia-reperfusion injury (e.g., cardiac ischemia-reperfusion injury) or myocardial infarction.
ISOXAZOLYL-CARBONYLOXY AZABICYCLO[3.2.1]OCTANYL COMPOUNDS AS FXR ACTIVATORS
-
Paragraph 00424, (2018/09/25)
The disclosure relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): wherein L1, L2, A, B, R1, R2, R3, and R4 are described herein.